NDA/BLA filedconf 0.70
sunosi — NDA/BLA filed
$AXSM · Axsome Therapeutics, Inc. · excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea
Event date
Date TBD
Sponsor runway
44 mo
$305.1M liquid
Evidence
Comparable historical nda/bla fileds· last 5 years · same event type
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $AXSM | — | 2025-12-31 | unknown |
| $RCKT | kresladi | 2025-10-14 | unknown |
| $ALDX | reproxalap | 2025-07-17 | unknown |
| $ETON | et-600 | 2025-07-08 | unknown |
| $BCRX | orladeyo (berotralstat) | 2025-05-14 | unknown |
| $CORT | relacorilant | 2025-03-03 | unknown |
| $ALDX | reproxalap | 2024-11-01 | unknown |
| $AXSM | axs-07 | 2024-09-04 | unknown |
| $RCKT | kresladi | 2023-10-02 | unknown |
| $GERN | imetelstat | 2023-08-21 | unknown |
Recent insider activity· ±90 days
1 insider · 0 buys · 2 sells
Exercise10b5-1
2026-05-05Jacobson Mark L.
Chief Operating Officer
233 @ $12.95$3K
Sell10b5-1
2026-05-05Jacobson Mark L.
Chief Operating Officer
233 @ $228.18$53K
Exercise10b5-1
2026-05-04Jacobson Mark L.
Chief Operating Officer
4,517 @ $12.95$58K
Sell10b5-1
2026-05-04Jacobson Mark L.
Chief Operating Officer
4,517 @ $227.94$1.03M